🇴🇲 Country Profile

Oman

Fast-growing pharmaceutical trade with Oman

🇴🇲 $60.0M
All data from DGCIS India export records (fiscal year, April–March).
$60.0M
Scale
Oman's healthcare system receives $60.0M in Indian pharmaceutical products each year, affordable, quality medicine.
66%
Medicine
Primarily medicines (66%), supplemented by medicine ingredients and surgical & hospital supplies.
3.7×
Trajectory
One of the faster-growing relationships, India's pharmaceutical supply to Oman has expanded 3.7× over the decade.
Context
Part of India's pharmaceutical supply network across Middle East.
Impact
Indian pharmaceutical companies have both exported to and invested directly in Oman, building trade and operational presence.
Export Trend DGCIS FY
Pharmaceutical Composition Trend DGCIS CY 2014–2025

All pharmaceutical categories from DGCIS

Category Mix, FY 2025–26 DGCIS
Medicines $39.8M (66.2%) Medicine Ingredients $14.7M (24.5%) Surgical & Hospital Supplies $3.0M (5.0%) Traditional & Herbal $1.4M (2.4%) Vaccines $1.1M (1.9%)
Top Products, FY 2025–26 DGCIS
Indian Pharma Investment in Oman Source: RBI ODI Data

Total RBI-approved ODI commitments by Indian pharmaceutical companies into Oman: $2.0M across 3 filings (2012-2013).